Video

The Current State of pDNA Manufacturing Platforms for mRNA Production

Source: Advancing RNA

In this Advancing RNA Live clip, Sanofi’s Nicolas Chaudet and Tune Therapeutics’ Tyler Goodwin share their perspectives on the current strengths and weaknesses of outsourced plasmid production. The discussion also homes in on the most important pDNA supplier capabilities mRNA producers should be keeping in mind as they select/work with partners. 

Access The Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)